Cerity Partners
RCKT icon

Cerity Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Cerity Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Buy
78,974
+56,182
+246% +$223K ﹤0.01% 2652
2025
Q4 		$80K Buy
22,792
+9,605
+73% +$32.9K ﹤0.01% 2776
2025
Q3 		$43K Buy
+13,187
New +$41.5K ﹤0.01% 2707

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cerity Partners's RCKT Position: Q1 2026 in Review

Cerity Partners increased its Rocket Pharmaceuticals (RCKT) stake by 246% in Q1 2026, buying an estimated $223K and bringing the position to 78,974 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Cerity Partners first reported a position in RCKT in Q3 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Cerity Partners held 78,974 shares of Rocket Pharmaceuticals worth $283K as of Q1 2026.
  • Cerity Partners bought 56,182 Rocket Pharmaceuticals shares in Q1 2026, an estimated $223K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2652 holding.
  • Cerity Partners first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.